Groupe la Francaise’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28M Buy
37,915
+4,118
+12% +$577K 0.07% 181
2025
Q4
$4.15M Sell
33,797
-251
-0.7% -$30.5K 0.06% 193
2025
Q3
$3.76M Sell
34,048
-1,442
-4% -$164K 0.05% 200
2025
Q2
$3.92M Buy
35,490
+33,226
+1,468% +$3.54M 0.06% 170
2025
Q1
$252K Buy
+2,264
New +$234K 0.01% 352

Other funds holding GILD

Groupe la Francaise's GILD Position: Q1 2026 in Review

Groupe la Francaise increased its Gilead Sciences (GILD) stake by 12% in Q1 2026, buying an estimated $577K and bringing the position to 37,915 shares worth $5.28M. The position accounts for 0.07% of the portfolio, ranked #181.

Groupe la Francaise first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Groupe la Francaise held 37,915 shares of Gilead Sciences worth $5.28M as of Q1 2026.
  • Groupe la Francaise bought 4,118 Gilead Sciences shares in Q1 2026, an estimated $577K.
  • Gilead Sciences made up 0.07% of Groupe la Francaise's portfolio in Q1 2026, its #181 holding.
  • Groupe la Francaise first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.